Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
Open Access
- 24 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 160 (1) , 173-179
Abstract
Pregnancy is a complex physiological state, in which the metabolism of endogenous as well as exogenous agents is ostensibly altered. One exogenous agent of concern is the hepatocarcinogen aflatoxin B1 (AFB1), a foodborne fungal toxin, that requires phase I metabolic oxidation for conversion to its toxic and carcinogenic form, the AFB1-8,9-exo-epoxide. The epoxide interacts with cellular targets causing toxicity and cell death; these targets include the covalent modification of DNA leading to mutations that can initiate malignant transformation. The main detoxification pathway of the AFB1-epoxide involves phase II metabolic enzymes including the glutathione-S-transferase (GST) family. Pregnancy can modulate both phase I and II metabolism and alter the biological potency of AFB1. The present work investigated the impact of pregnancy on AFB1 exposure in mice. A single IP dose of 6 mg/kg AFB1 was administered to pregnant C57BL/6 J mice at gestation day 14 and matched non-pregnant controls. Pregnant mice accumulated 2-fold higher AFB1-N7-guanine DNA adducts in the liver when compared with nonpregnant controls 6 h post-exposure. Enhanced DNA adduct formation in pregnant animals paralleled elevated hepatic protein expression of mouse CYP1A2 and mouse homologs of human CYP3A4, phase I enzymes capable of bioactivating AFB1. Although phase II enzymes GSTA1/2 showed decreased protein expression, GSTA3, the primary enzymatic protection against the AFB1-epoxide, was unaffected at the protein level. Taken together, our results reveal that pregnancy may constitute a critical window of susceptibility for maternal health, and provide insight into the biochemical factors that could explain the underlying risks.Keywords
Funding Information
- National Institutes of Health (T32-ES007020, P30-ES002109, R01-ES016313, R01-CA080024, P30-CA006973)
This publication has 45 references indexed in Scilit:
- Mutational spectra of aflatoxin B 1 in vivo establish biomarkers of exposure for human hepatocellular carcinomaProceedings of the National Academy of Sciences, 2017
- Exposure to aflatoxin B1in uterois associated with DNA methylation in white blood cells of infants in The GambiaInternational Journal of Epidemiology, 2015
- Drug Metabolism and Transport During Pregnancy: How Does Drug Disposition Change during Pregnancy and What Are the Mechanisms that Cause Such Changes?Drug Metabolism and Disposition, 2013
- Aflatoxin B1-DNA Adduct Formation and Mutagenicity in Livers of Neonatal Male and Female B6C3F1 MiceToxicological Sciences, 2011
- Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk AssessmentEnvironmental Health Perspectives, 2010
- Mycotoxins and human disease: a largely ignored global health issueCarcinogenesis, 2009
- Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience, 2007
- Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized miceToxicology Letters, 2004
- A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.1994
- Detection of aflatoxin B1-DNA adducts in human placenta and cord blood.1993